Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for DLX4_HOXD8
Z-value: 0.93
Motif logo
Transcription factors associated with DLX4_HOXD8
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
DLX4
|
ENSG00000108813.11 | DLX4 |
|
HOXD8
|
ENSG00000175879.9 | HOXD8 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| DLX4 | hg38_v1_chr17_+_49969178_49969214 | 0.15 | 2.6e-02 | Click! |
Activity profile of DLX4_HOXD8 motif
Sorted Z-values of DLX4_HOXD8 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of DLX4_HOXD8
| Promoter | Score | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_+_90038848 | 25.96 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
| chr2_+_90100235 | 20.63 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr2_-_89100352 | 18.13 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
| chr8_-_85341705 | 17.39 |
ENST00000517618.5
|
CA1
|
carbonic anhydrase 1 |
| chr2_+_90172802 | 15.77 |
ENST00000390277.3
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
| chr2_+_90209873 | 15.71 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
| chr7_+_142791635 | 13.92 |
ENST00000633705.1
|
TRBC1
|
T cell receptor beta constant 1 |
| chr2_+_90159840 | 13.40 |
ENST00000377032.5
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
| chr2_-_88979016 | 12.47 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr2_-_89117844 | 12.40 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chr2_+_89851723 | 12.13 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
| chr2_+_87338511 | 12.08 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
| chr2_-_88857582 | 12.06 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
| chr2_+_90234809 | 11.62 |
ENST00000443397.5
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
| chr8_-_85341659 | 11.55 |
ENST00000522389.5
|
CA1
|
carbonic anhydrase 1 |
| chr14_-_106470788 | 11.36 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
| chr4_-_73988179 | 10.41 |
ENST00000296028.4
|
PPBP
|
pro-platelet basic protein |
| chrX_+_1591590 | 10.36 |
ENST00000313871.9
ENST00000381261.8 |
AKAP17A
|
A-kinase anchoring protein 17A |
| chr2_-_89213917 | 9.45 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr2_-_89085787 | 9.01 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
| chr11_-_60183011 | 8.64 |
ENST00000533023.5
ENST00000420732.6 ENST00000528851.6 |
MS4A6A
|
membrane spanning 4-domains A6A |
| chr15_+_88635626 | 8.21 |
ENST00000379224.10
|
ISG20
|
interferon stimulated exonuclease gene 20 |
| chr1_-_158686700 | 8.20 |
ENST00000643759.2
|
SPTA1
|
spectrin alpha, erythrocytic 1 |
| chr6_-_32941018 | 8.07 |
ENST00000418107.3
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta |
| chr12_-_14950606 | 7.49 |
ENST00000536592.5
|
ARHGDIB
|
Rho GDP dissociation inhibitor beta |
| chr15_+_75347030 | 7.43 |
ENST00000566313.5
ENST00000355059.9 ENST00000568059.1 ENST00000568881.1 |
NEIL1
|
nei like DNA glycosylase 1 |
| chr14_-_106593319 | 7.39 |
ENST00000390627.3
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
| chr7_-_77199808 | 7.33 |
ENST00000248598.6
|
FGL2
|
fibrinogen like 2 |
| chr22_+_22711689 | 7.25 |
ENST00000390308.2
|
IGLV3-21
|
immunoglobulin lambda variable 3-21 |
| chr6_+_32439866 | 6.95 |
ENST00000374982.5
ENST00000395388.7 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
| chr17_+_69502397 | 6.86 |
ENST00000613873.4
ENST00000589647.5 |
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
| chr11_+_5689780 | 6.86 |
ENST00000379965.8
ENST00000454828.5 |
TRIM22
|
tripartite motif containing 22 |
| chr2_+_89913982 | 6.83 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
| chr2_-_88947820 | 6.60 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr14_-_106277039 | 6.40 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
| chr12_+_25052634 | 6.35 |
ENST00000548766.5
|
IRAG2
|
inositol 1,4,5-triphosphate receptor associated 2 |
| chr2_-_136118142 | 6.35 |
ENST00000241393.4
|
CXCR4
|
C-X-C motif chemokine receptor 4 |
| chr2_-_89040745 | 6.25 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chr2_+_89884740 | 6.19 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
| chr12_+_25052732 | 6.15 |
ENST00000547044.5
|
IRAG2
|
inositol 1,4,5-triphosphate receptor associated 2 |
| chr4_-_70666492 | 6.11 |
ENST00000254801.9
ENST00000391614.7 |
JCHAIN
|
joining chain of multimeric IgA and IgM |
| chr12_-_10130241 | 6.05 |
ENST00000353231.9
ENST00000525605.1 |
CLEC7A
|
C-type lectin domain containing 7A |
| chr6_+_32741382 | 5.97 |
ENST00000374940.4
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
| chr4_+_40197023 | 5.96 |
ENST00000381799.10
|
RHOH
|
ras homolog family member H |
| chr14_-_106185387 | 5.91 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
| chr2_-_89143133 | 5.88 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
| chr4_+_40196907 | 5.75 |
ENST00000622175.4
ENST00000619474.4 ENST00000615083.4 ENST00000610353.4 ENST00000614836.1 |
RHOH
|
ras homolog family member H |
| chr12_+_9827472 | 5.73 |
ENST00000617793.4
ENST00000617889.5 ENST00000354855.7 ENST00000279545.7 |
KLRF1
|
killer cell lectin like receptor F1 |
| chr1_+_158831323 | 5.69 |
ENST00000368141.5
|
MNDA
|
myeloid cell nuclear differentiation antigen |
| chr3_-_39280021 | 5.65 |
ENST00000399220.3
|
CX3CR1
|
C-X3-C motif chemokine receptor 1 |
| chr1_-_92486916 | 5.48 |
ENST00000294702.6
|
GFI1
|
growth factor independent 1 transcriptional repressor |
| chr2_+_90114838 | 5.47 |
ENST00000417279.3
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 |
| chr11_-_60183191 | 5.41 |
ENST00000412309.6
|
MS4A6A
|
membrane spanning 4-domains A6A |
| chr10_+_7703340 | 5.39 |
ENST00000429820.5
ENST00000379587.4 |
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
| chr12_-_10130143 | 5.37 |
ENST00000298523.9
ENST00000396484.6 ENST00000310002.4 ENST00000304084.13 |
CLEC7A
|
C-type lectin domain containing 7A |
| chr2_+_90069662 | 5.36 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
| chr5_+_157269317 | 5.26 |
ENST00000618329.4
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr4_-_99435134 | 5.26 |
ENST00000476959.5
ENST00000482593.5 |
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
| chr14_-_106269133 | 5.12 |
ENST00000390609.3
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr6_+_29301701 | 5.08 |
ENST00000641895.1
|
OR14J1
|
olfactory receptor family 14 subfamily J member 1 |
| chr1_+_198638968 | 5.07 |
ENST00000348564.11
ENST00000530727.5 ENST00000442510.8 ENST00000645247.1 ENST00000367367.8 ENST00000367364.5 ENST00000413409.6 |
PTPRC
|
protein tyrosine phosphatase receptor type C |
| chr1_-_183590876 | 5.06 |
ENST00000367536.5
|
NCF2
|
neutrophil cytosolic factor 2 |
| chr19_+_49513353 | 5.00 |
ENST00000596975.5
|
FCGRT
|
Fc fragment of IgG receptor and transporter |
| chr11_+_56027654 | 4.85 |
ENST00000641320.1
|
OR5AS1
|
olfactory receptor family 5 subfamily AS member 1 |
| chr14_-_106737547 | 4.79 |
ENST00000632209.1
|
IGHV1-69-2
|
immunoglobulin heavy variable 1-69-2 |
| chr17_-_35880350 | 4.78 |
ENST00000605140.6
ENST00000651122.1 ENST00000603197.6 |
CCL5
|
C-C motif chemokine ligand 5 |
| chr12_-_7503744 | 4.75 |
ENST00000396620.7
ENST00000432237.3 |
CD163
|
CD163 molecule |
| chr13_+_50909905 | 4.68 |
ENST00000644034.1
ENST00000645955.1 |
RNASEH2B
|
ribonuclease H2 subunit B |
| chr17_+_36103819 | 4.61 |
ENST00000615863.2
ENST00000621626.1 |
CCL4
|
C-C motif chemokine ligand 4 |
| chr14_-_24609660 | 4.58 |
ENST00000557220.6
ENST00000216338.9 ENST00000382548.4 |
GZMH
|
granzyme H |
| chr21_-_14546297 | 4.51 |
ENST00000400566.6
ENST00000400564.5 |
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1 |
| chr16_-_28623560 | 4.51 |
ENST00000350842.8
|
SULT1A1
|
sulfotransferase family 1A member 1 |
| chr16_+_58249910 | 4.50 |
ENST00000219299.8
ENST00000443128.6 ENST00000616795.1 |
CCDC113
|
coiled-coil domain containing 113 |
| chr7_-_116030750 | 4.47 |
ENST00000265440.12
ENST00000320239.11 |
TFEC
|
transcription factor EC |
| chr2_-_86105839 | 4.47 |
ENST00000263857.11
|
POLR1A
|
RNA polymerase I subunit A |
| chr1_+_84181630 | 4.46 |
ENST00000610457.1
|
PRKACB
|
protein kinase cAMP-activated catalytic subunit beta |
| chr2_+_88885397 | 4.46 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
| chr2_+_90021567 | 4.44 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
| chr10_+_7703300 | 4.43 |
ENST00000358415.9
|
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
| chrX_+_37780049 | 4.43 |
ENST00000378588.5
|
CYBB
|
cytochrome b-245 beta chain |
| chr4_-_99435336 | 4.43 |
ENST00000437033.7
|
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
| chr7_-_116030735 | 4.41 |
ENST00000393485.5
|
TFEC
|
transcription factor EC |
| chr11_-_5243644 | 4.41 |
ENST00000643122.1
|
HBD
|
hemoglobin subunit delta |
| chr2_-_89027700 | 4.41 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
| chr2_-_70248598 | 4.38 |
ENST00000445587.5
ENST00000433529.7 ENST00000415783.6 |
TIA1
|
TIA1 cytotoxic granule associated RNA binding protein |
| chr12_-_11269696 | 4.37 |
ENST00000381842.7
|
PRB3
|
proline rich protein BstNI subfamily 3 |
| chr8_-_30812867 | 4.35 |
ENST00000518243.5
|
PPP2CB
|
protein phosphatase 2 catalytic subunit beta |
| chr18_+_74534594 | 4.32 |
ENST00000582365.1
|
CNDP1
|
carnosine dipeptidase 1 |
| chr12_+_9669735 | 4.27 |
ENST00000545918.5
ENST00000543300.5 ENST00000261339.10 ENST00000466035.6 |
CLEC2D
|
C-type lectin domain family 2 member D |
| chr2_+_102418642 | 4.15 |
ENST00000264260.6
|
IL18RAP
|
interleukin 18 receptor accessory protein |
| chr3_+_46370854 | 4.15 |
ENST00000292303.4
|
CCR5
|
C-C motif chemokine receptor 5 |
| chr19_-_54313074 | 4.12 |
ENST00000486742.2
ENST00000432233.8 |
LILRA5
|
leukocyte immunoglobulin like receptor A5 |
| chr2_-_159798043 | 4.10 |
ENST00000664982.1
ENST00000259053.6 |
ENSG00000287091.1
CD302
|
novel transcript, sense intronic to CD302and LY75-CD302 CD302 molecule |
| chr11_-_85665077 | 4.08 |
ENST00000527447.2
|
CREBZF
|
CREB/ATF bZIP transcription factor |
| chr3_+_178419123 | 4.02 |
ENST00000614557.1
ENST00000455307.5 ENST00000436432.1 |
ENSG00000275163.1
LINC01014
|
potassium large conductance calcium-activated channel, subfamily M, beta member 2 (KCNMB2-IT1 - KCNMB2 readthrough transcript) long intergenic non-protein coding RNA 1014 |
| chr5_-_135954962 | 4.01 |
ENST00000522943.5
ENST00000514447.2 ENST00000274507.6 |
LECT2
|
leukocyte cell derived chemotaxin 2 |
| chr2_+_90220727 | 4.00 |
ENST00000471857.2
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
| chr21_-_14546351 | 4.00 |
ENST00000619120.4
|
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1 |
| chr8_+_38728186 | 3.94 |
ENST00000519416.5
ENST00000520615.5 |
TACC1
|
transforming acidic coiled-coil containing protein 1 |
| chr4_-_46909206 | 3.90 |
ENST00000396533.5
|
COX7B2
|
cytochrome c oxidase subunit 7B2 |
| chr4_+_25160631 | 3.89 |
ENST00000510415.1
ENST00000507794.2 ENST00000512921.4 |
SEPSECS-AS1
PI4K2B
|
SEPSECS antisense RNA 1 (head to head) phosphatidylinositol 4-kinase type 2 beta |
| chr7_-_38249572 | 3.84 |
ENST00000436911.6
|
TRGC2
|
T cell receptor gamma constant 2 |
| chr14_+_20955484 | 3.80 |
ENST00000304625.3
|
RNASE2
|
ribonuclease A family member 2 |
| chr2_-_157444044 | 3.78 |
ENST00000264192.8
|
CYTIP
|
cytohesin 1 interacting protein |
| chr17_+_58238426 | 3.78 |
ENST00000421678.6
ENST00000262290.9 ENST00000543544.5 |
LPO
|
lactoperoxidase |
| chr2_-_89320146 | 3.76 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 |
| chr9_-_21368962 | 3.75 |
ENST00000610660.1
|
IFNA13
|
interferon alpha 13 |
| chr8_-_33567118 | 3.74 |
ENST00000256257.2
|
RNF122
|
ring finger protein 122 |
| chr6_-_52840843 | 3.74 |
ENST00000370989.6
|
GSTA5
|
glutathione S-transferase alpha 5 |
| chr17_+_36211055 | 3.73 |
ENST00000617405.5
ENST00000617416.4 ENST00000613173.4 ENST00000620732.4 ENST00000620098.4 ENST00000620576.4 ENST00000620055.4 ENST00000610565.4 ENST00000620250.1 |
CCL4L2
|
C-C motif chemokine ligand 4 like 2 |
| chr16_+_33009175 | 3.73 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
| chr22_+_22322452 | 3.73 |
ENST00000390290.3
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
| chr1_-_113871665 | 3.70 |
ENST00000528414.5
ENST00000460620.5 ENST00000359785.10 ENST00000420377.6 ENST00000525799.1 ENST00000538253.5 |
PTPN22
|
protein tyrosine phosphatase non-receptor type 22 |
| chrX_+_10158448 | 3.69 |
ENST00000380829.5
ENST00000421085.7 ENST00000674669.1 ENST00000454850.1 |
CLCN4
|
chloride voltage-gated channel 4 |
| chr4_-_46909235 | 3.67 |
ENST00000505102.1
ENST00000355591.8 |
COX7B2
|
cytochrome c oxidase subunit 7B2 |
| chr2_+_89936859 | 3.65 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
| chr11_+_49028823 | 3.63 |
ENST00000332682.9
|
TRIM49B
|
tripartite motif containing 49B |
| chr12_-_11269805 | 3.63 |
ENST00000538488.2
|
PRB3
|
proline rich protein BstNI subfamily 3 |
| chr16_-_33845229 | 3.63 |
ENST00000569103.2
|
IGHV3OR16-17
|
immunoglobulin heavy variable 3/OR16-17 (non-functional) |
| chr3_+_149474688 | 3.63 |
ENST00000305354.5
ENST00000465758.1 |
TM4SF4
|
transmembrane 4 L six family member 4 |
| chr12_-_14961559 | 3.50 |
ENST00000228945.9
ENST00000541546.5 |
ARHGDIB
|
Rho GDP dissociation inhibitor beta |
| chr15_-_19988117 | 3.48 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
| chr11_-_102705737 | 3.46 |
ENST00000260229.5
|
MMP27
|
matrix metallopeptidase 27 |
| chr2_-_159798234 | 3.43 |
ENST00000429078.6
ENST00000553424.5 |
CD302
|
CD302 molecule |
| chr20_-_1657714 | 3.39 |
ENST00000216927.4
ENST00000344103.8 |
SIRPG
|
signal regulatory protein gamma |
| chr3_-_39281663 | 3.36 |
ENST00000358309.3
|
CX3CR1
|
C-X3-C motif chemokine receptor 1 |
| chr1_-_150765785 | 3.32 |
ENST00000680311.1
ENST00000681728.1 ENST00000680288.1 |
CTSS
|
cathepsin S |
| chr6_-_132763424 | 3.32 |
ENST00000532012.1
ENST00000525270.5 ENST00000530536.5 ENST00000524919.5 |
VNN2
|
vanin 2 |
| chr13_-_46182136 | 3.30 |
ENST00000323076.7
|
LCP1
|
lymphocyte cytosolic protein 1 |
| chr14_-_22957100 | 3.30 |
ENST00000555367.5
|
HAUS4
|
HAUS augmin like complex subunit 4 |
| chr4_-_39032343 | 3.29 |
ENST00000381938.4
|
TMEM156
|
transmembrane protein 156 |
| chr16_+_32066065 | 3.27 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
| chr21_-_14658812 | 3.26 |
ENST00000647101.1
|
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1 |
| chr14_-_24576240 | 3.24 |
ENST00000216336.3
|
CTSG
|
cathepsin G |
| chr4_+_101813810 | 3.23 |
ENST00000444316.2
|
BANK1
|
B cell scaffold protein with ankyrin repeats 1 |
| chr4_-_69214743 | 3.21 |
ENST00000446444.2
|
UGT2B11
|
UDP glucuronosyltransferase family 2 member B11 |
| chr3_+_35680994 | 3.19 |
ENST00000441454.5
|
ARPP21
|
cAMP regulated phosphoprotein 21 |
| chr5_+_55102635 | 3.18 |
ENST00000274306.7
|
GZMA
|
granzyme A |
| chr12_-_122500520 | 3.17 |
ENST00000540586.1
ENST00000543897.5 |
ZCCHC8
|
zinc finger CCHC-type containing 8 |
| chr11_-_129024157 | 3.16 |
ENST00000392657.7
|
ARHGAP32
|
Rho GTPase activating protein 32 |
| chr16_+_33802683 | 3.15 |
ENST00000570121.2
|
IGHV3OR16-12
|
immunoglobulin heavy variable 3/OR16-12 (non-functional) |
| chr17_-_37643422 | 3.10 |
ENST00000617633.5
|
DDX52
|
DExD-box helicase 52 |
| chr8_+_28891304 | 3.09 |
ENST00000355231.9
|
HMBOX1
|
homeobox containing 1 |
| chr22_-_18936142 | 3.08 |
ENST00000438924.5
ENST00000457083.1 ENST00000357068.11 ENST00000420436.5 ENST00000334029.6 ENST00000610940.4 |
PRODH
|
proline dehydrogenase 1 |
| chr5_-_20575850 | 3.07 |
ENST00000507958.5
|
CDH18
|
cadherin 18 |
| chr5_+_140848360 | 3.05 |
ENST00000532602.2
|
PCDHA9
|
protocadherin alpha 9 |
| chr7_+_74209386 | 3.04 |
ENST00000344995.9
|
LAT2
|
linker for activation of T cells family member 2 |
| chr6_-_52763473 | 3.03 |
ENST00000493422.3
|
GSTA2
|
glutathione S-transferase alpha 2 |
| chr17_-_64390852 | 3.03 |
ENST00000563924.6
|
PECAM1
|
platelet and endothelial cell adhesion molecule 1 |
| chr7_-_150323489 | 3.02 |
ENST00000683684.1
ENST00000478393.5 |
ACTR3C
|
actin related protein 3C |
| chr12_-_9607903 | 3.01 |
ENST00000229402.4
|
KLRB1
|
killer cell lectin like receptor B1 |
| chr11_+_121576760 | 3.01 |
ENST00000532694.5
ENST00000534286.5 |
SORL1
|
sortilin related receptor 1 |
| chr6_-_49744434 | 2.98 |
ENST00000433368.6
ENST00000354620.4 |
CRISP3
|
cysteine rich secretory protein 3 |
| chr4_+_68815991 | 2.98 |
ENST00000265403.12
ENST00000458688.2 |
UGT2B10
|
UDP glucuronosyltransferase family 2 member B10 |
| chr14_-_106005574 | 2.95 |
ENST00000390595.3
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
| chr14_-_22957061 | 2.92 |
ENST00000557591.5
ENST00000541587.6 ENST00000490506.5 ENST00000554406.1 |
HAUS4
|
HAUS augmin like complex subunit 4 |
| chr1_+_174875505 | 2.91 |
ENST00000486220.5
|
RABGAP1L
|
RAB GTPase activating protein 1 like |
| chr2_+_165239432 | 2.90 |
ENST00000636071.2
ENST00000636985.2 |
SCN2A
|
sodium voltage-gated channel alpha subunit 2 |
| chr1_-_207052980 | 2.89 |
ENST00000367084.1
|
YOD1
|
YOD1 deubiquitinase |
| chr12_+_25052512 | 2.88 |
ENST00000557489.5
ENST00000354454.7 ENST00000536173.5 |
IRAG2
|
inositol 1,4,5-triphosphate receptor associated 2 |
| chr2_+_68734861 | 2.87 |
ENST00000467265.5
|
ARHGAP25
|
Rho GTPase activating protein 25 |
| chr20_-_36951837 | 2.87 |
ENST00000262878.5
|
SAMHD1
|
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 |
| chr6_+_139135063 | 2.87 |
ENST00000367658.3
|
HECA
|
hdc homolog, cell cycle regulator |
| chr4_-_152382522 | 2.86 |
ENST00000296555.11
|
FBXW7
|
F-box and WD repeat domain containing 7 |
| chrY_-_6872608 | 2.84 |
ENST00000383036.1
|
AMELY
|
amelogenin Y-linked |
| chrX_+_109536641 | 2.84 |
ENST00000372107.5
|
NXT2
|
nuclear transport factor 2 like export factor 2 |
| chr5_-_132556809 | 2.84 |
ENST00000450655.1
|
IL5
|
interleukin 5 |
| chr6_-_132734692 | 2.82 |
ENST00000509351.5
ENST00000417437.6 ENST00000423615.6 ENST00000427187.6 ENST00000414302.7 ENST00000367927.9 ENST00000450865.2 |
VNN3
|
vanin 3 |
| chr4_+_69280472 | 2.79 |
ENST00000335568.10
ENST00000511240.1 |
UGT2B28
|
UDP glucuronosyltransferase family 2 member B28 |
| chr2_+_165239388 | 2.78 |
ENST00000424833.5
ENST00000375437.7 ENST00000631182.3 |
SCN2A
|
sodium voltage-gated channel alpha subunit 2 |
| chr16_+_10386049 | 2.78 |
ENST00000562527.5
ENST00000396559.5 ENST00000396560.6 ENST00000562102.5 ENST00000543967.5 ENST00000569939.5 ENST00000569900.5 |
ATF7IP2
|
activating transcription factor 7 interacting protein 2 |
| chr1_+_27872536 | 2.76 |
ENST00000328928.11
ENST00000373921.8 ENST00000373925.5 ENST00000373927.7 ENST00000427466.1 ENST00000442118.5 |
THEMIS2
|
thymocyte selection associated family member 2 |
| chr12_+_9827517 | 2.73 |
ENST00000537723.5
|
KLRF1
|
killer cell lectin like receptor F1 |
| chr2_-_89297785 | 2.72 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
| chr8_-_133102477 | 2.72 |
ENST00000522119.5
ENST00000523610.5 ENST00000338087.10 ENST00000521302.5 ENST00000519558.5 ENST00000519747.5 ENST00000517648.5 |
SLA
|
Src like adaptor |
| chr12_+_8843236 | 2.70 |
ENST00000541459.5
|
A2ML1
|
alpha-2-macroglobulin like 1 |
| chr20_+_24949256 | 2.69 |
ENST00000480798.2
|
CST7
|
cystatin F |
| chr12_-_7503841 | 2.68 |
ENST00000359156.8
|
CD163
|
CD163 molecule |
| chr4_-_99435396 | 2.66 |
ENST00000209665.8
|
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
| chr1_+_207053229 | 2.65 |
ENST00000367080.8
ENST00000367079.3 |
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
| chr2_+_68734773 | 2.64 |
ENST00000409202.8
|
ARHGAP25
|
Rho GTPase activating protein 25 |
| chr4_+_40191037 | 2.63 |
ENST00000505618.5
|
RHOH
|
ras homolog family member H |
| chr15_-_19965101 | 2.63 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
| chr14_-_22957128 | 2.60 |
ENST00000342454.12
ENST00000555986.5 ENST00000554516.5 ENST00000347758.6 ENST00000206474.11 ENST00000555040.5 |
HAUS4
|
HAUS augmin like complex subunit 4 |
| chr19_-_40413364 | 2.60 |
ENST00000291825.11
ENST00000324001.8 |
PRX
|
periaxin |
| chr12_+_11649666 | 2.58 |
ENST00000396373.9
|
ETV6
|
ETS variant transcription factor 6 |
| chr14_+_92121953 | 2.56 |
ENST00000298875.9
ENST00000553427.5 |
CPSF2
|
cleavage and polyadenylation specific factor 2 |
| chr3_+_4680617 | 2.56 |
ENST00000648212.1
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor type 1 |
| chr1_+_117420597 | 2.53 |
ENST00000449370.6
|
MAN1A2
|
mannosidase alpha class 1A member 2 |
| chr12_-_53207271 | 2.53 |
ENST00000552972.5
ENST00000422257.7 |
ITGB7
|
integrin subunit beta 7 |
| chr12_+_56468561 | 2.52 |
ENST00000338146.7
|
SPRYD4
|
SPRY domain containing 4 |
| chr4_-_67545464 | 2.51 |
ENST00000273853.11
|
CENPC
|
centromere protein C |
| chr16_-_21652598 | 2.51 |
ENST00000569602.1
ENST00000268389.6 |
IGSF6
|
immunoglobulin superfamily member 6 |
| chr2_+_143129379 | 2.50 |
ENST00000295095.11
|
ARHGAP15
|
Rho GTPase activating protein 15 |
| chr15_+_90352239 | 2.50 |
ENST00000354377.8
ENST00000379090.9 |
ZNF774
|
zinc finger protein 774 |
| chr4_+_69096467 | 2.49 |
ENST00000305231.12
|
UGT2B7
|
UDP glucuronosyltransferase family 2 member B7 |
| chr12_+_133181409 | 2.49 |
ENST00000416488.5
ENST00000228289.9 ENST00000541211.6 ENST00000536435.7 ENST00000500625.7 ENST00000539248.6 ENST00000542711.6 ENST00000536899.6 ENST00000542986.6 ENST00000611984.4 ENST00000541975.2 |
ZNF268
|
zinc finger protein 268 |
| chr9_-_86354386 | 2.47 |
ENST00000277141.10
ENST00000375963.8 |
TUT7
|
terminal uridylyl transferase 7 |
| chr2_-_89222461 | 2.45 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
| chr15_+_99251362 | 2.45 |
ENST00000558879.5
ENST00000301981.8 ENST00000447360.6 ENST00000558172.5 ENST00000561276.5 ENST00000331450.9 |
LRRC28
|
leucine rich repeat containing 28 |
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.0 | 15.0 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 3.7 | 11.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 3.1 | 12.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 2.7 | 8.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 2.3 | 6.9 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 2.3 | 9.0 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 1.8 | 272.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 1.8 | 5.5 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.8 | 5.3 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 1.7 | 5.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 1.7 | 5.0 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.6 | 9.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 1.6 | 4.7 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 1.5 | 4.4 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.2 | 4.7 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 1.2 | 7.0 | GO:0097338 | response to clozapine(GO:0097338) |
| 1.1 | 3.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 1.1 | 3.3 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 1.1 | 3.3 | GO:0034769 | basement membrane disassembly(GO:0034769) |
| 1.1 | 3.3 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 1.1 | 4.3 | GO:0045401 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 1.1 | 4.2 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 1.0 | 10.5 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 1.0 | 3.0 | GO:1902948 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) regulation of neurofibrillary tangle assembly(GO:1902996) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 1.0 | 3.0 | GO:0050904 | diapedesis(GO:0050904) |
| 1.0 | 3.9 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.9 | 3.8 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
| 0.9 | 9.3 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.9 | 3.6 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.9 | 1.8 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.9 | 2.7 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.9 | 3.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.9 | 6.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.9 | 3.4 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.8 | 10.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.8 | 2.5 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.8 | 3.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.8 | 8.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.8 | 2.4 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.8 | 3.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.8 | 2.3 | GO:1903004 | regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
| 0.8 | 7.6 | GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.7 | 12.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.7 | 3.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.7 | 2.1 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.7 | 7.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.7 | 1.3 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.6 | 107.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.6 | 4.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.6 | 2.6 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.6 | 2.5 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.6 | 2.5 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 0.6 | 1.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.6 | 1.8 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.6 | 4.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.6 | 2.3 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.6 | 1.7 | GO:0031393 | negative regulation of prostaglandin biosynthetic process(GO:0031393) |
| 0.6 | 1.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.5 | 1.1 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.5 | 31.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.5 | 3.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.5 | 3.2 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.5 | 0.5 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.5 | 2.1 | GO:1902857 | nonmotile primary cilium assembly(GO:0035058) regulation of nonmotile primary cilium assembly(GO:1902855) positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.5 | 0.5 | GO:1903487 | regulation of lactation(GO:1903487) |
| 0.5 | 2.6 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
| 0.5 | 2.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.5 | 10.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.5 | 5.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.5 | 1.5 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.5 | 4.0 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
| 0.5 | 6.5 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.5 | 14.9 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.5 | 2.0 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.5 | 9.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.5 | 1.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.5 | 0.5 | GO:0015942 | formate metabolic process(GO:0015942) histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.5 | 1.4 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.5 | 1.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.4 | 1.3 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.4 | 2.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.4 | 2.5 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.4 | 1.2 | GO:0060003 | copper ion export(GO:0060003) |
| 0.4 | 2.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.4 | 1.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.4 | 2.9 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.4 | 2.0 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.4 | 1.6 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
| 0.4 | 1.2 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.4 | 3.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.4 | 4.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 | 1.1 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.4 | 6.0 | GO:0098712 | amino acid import across plasma membrane(GO:0089718) L-glutamate import across plasma membrane(GO:0098712) |
| 0.4 | 1.1 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.4 | 0.7 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.4 | 2.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.4 | 1.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.3 | 2.0 | GO:0051945 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
| 0.3 | 1.7 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.3 | 1.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.3 | 0.7 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.3 | 1.0 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.3 | 1.3 | GO:2001193 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) negative regulation of interferon-gamma biosynthetic process(GO:0045077) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
| 0.3 | 2.6 | GO:0003138 | regulation of germinal center formation(GO:0002634) primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.3 | 2.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.3 | 2.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.3 | 2.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.3 | 2.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.3 | 0.6 | GO:0002331 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
| 0.3 | 0.6 | GO:1905237 | response to cyclosporin A(GO:1905237) |
| 0.3 | 0.9 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 0.3 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
| 0.3 | 1.5 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.3 | 0.9 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.3 | 0.9 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.3 | 2.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.3 | 0.9 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.3 | 1.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.3 | 0.9 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.3 | 2.0 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.3 | 0.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.3 | 1.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.3 | 0.3 | GO:0090212 | negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.3 | 1.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.3 | 0.8 | GO:1903718 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) cellular response to oleic acid(GO:0071400) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.3 | 1.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.3 | 0.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.2 | 0.7 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
| 0.2 | 16.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.2 | 1.0 | GO:0060023 | soft palate development(GO:0060023) |
| 0.2 | 2.4 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.2 | 1.0 | GO:0090301 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.2 | 1.2 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.2 | 1.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.2 | 1.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.2 | 0.5 | GO:0035691 | macrophage migration inhibitory factor signaling pathway(GO:0035691) |
| 0.2 | 1.6 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.2 | 0.9 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.2 | 0.7 | GO:0061150 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) deltoid tuberosity development(GO:0035993) intermediate mesoderm development(GO:0048389) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) pattern specification involved in mesonephros development(GO:0061227) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in kidney development(GO:0072098) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.2 | 1.4 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.2 | 0.7 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.2 | 2.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 | 0.2 | GO:1903781 | positive regulation of cardiac conduction(GO:1903781) |
| 0.2 | 0.7 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.2 | 0.9 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.2 | 4.8 | GO:0034505 | tooth mineralization(GO:0034505) |
| 0.2 | 0.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 0.2 | 0.6 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.2 | 5.1 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.2 | 3.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.2 | 2.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.2 | 2.0 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.2 | 3.8 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.2 | 1.0 | GO:1901963 | glial cell fate determination(GO:0007403) oviduct development(GO:0060066) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.2 | 1.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 1.4 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.2 | 0.6 | GO:0007343 | egg activation(GO:0007343) |
| 0.2 | 10.7 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.2 | 3.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.2 | 0.6 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.2 | 1.2 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.2 | 8.4 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.2 | 1.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.2 | 0.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.2 | 1.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.2 | 0.8 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.2 | 3.6 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 1.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.2 | 4.3 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
| 0.2 | 4.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.2 | 1.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.2 | 1.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.2 | 0.7 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.2 | 0.6 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
| 0.2 | 2.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 0.7 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.2 | 0.7 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.2 | 0.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 | 1.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.2 | 2.9 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.2 | 1.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.2 | 0.3 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.2 | 3.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.2 | 1.7 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.2 | 7.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.2 | 0.7 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.2 | 0.9 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 | 2.7 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
| 0.2 | 2.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.2 | 1.6 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.2 | 0.5 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
| 0.2 | 2.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.2 | 1.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 | 0.6 | GO:1904640 | response to methionine(GO:1904640) |
| 0.2 | 0.6 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.2 | 2.2 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.2 | 1.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.2 | 2.8 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.2 | 0.5 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.2 | 1.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.2 | 1.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.2 | 0.3 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.2 | 1.4 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 1.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 1.0 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 14.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.1 | 1.0 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.1 | 0.6 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 | 1.3 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.1 | 0.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.1 | 1.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.1 | 1.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.1 | 1.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 | 2.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.1 | 2.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.4 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.1 | 0.5 | GO:0043201 | response to leucine(GO:0043201) |
| 0.1 | 0.5 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.1 | 0.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 | 1.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 2.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
| 0.1 | 1.5 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 | 0.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 0.5 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.1 | 1.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.1 | 1.2 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.1 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 2.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.1 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 1.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 1.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 0.8 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.1 | 0.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 | 1.0 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 | 5.8 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
| 0.1 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 5.8 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.1 | 0.3 | GO:0036233 | glycine import(GO:0036233) |
| 0.1 | 0.5 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 | 0.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.3 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.1 | 0.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 | 1.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 | 0.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.1 | 0.3 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.1 | 0.4 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 | 0.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.1 | 1.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 | 2.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 | 0.8 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.1 | 1.6 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.1 | 1.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.1 | 4.3 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.1 | 1.1 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 2.7 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.1 | 2.9 | GO:0033198 | response to ATP(GO:0033198) |
| 0.1 | 1.0 | GO:0048263 | determination of dorsal identity(GO:0048263) |
| 0.1 | 1.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.1 | 0.6 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 0.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 2.9 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.1 | 1.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 0.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.1 | 2.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.1 | 0.7 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
| 0.1 | 2.5 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 0.9 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 2.6 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.1 | 4.7 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 4.7 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.1 | 1.7 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.1 | 0.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.1 | 0.2 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
| 0.1 | 0.8 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 | 2.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.1 | 1.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 0.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 0.6 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
| 0.1 | 2.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.1 | 0.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.1 | 0.4 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 | 1.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 1.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.1 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.1 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.5 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.1 | 1.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 0.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.1 | 1.3 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.1 | 6.3 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.1 | 0.1 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
| 0.1 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 1.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 5.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 | 2.1 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.1 | 0.5 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.1 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.2 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 0.1 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 1.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 1.8 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
| 0.1 | 0.9 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.1 | 1.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 2.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 | 0.8 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.1 | 1.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 | 1.6 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.1 | 3.1 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.1 | 0.2 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 1.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 0.9 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.1 | 1.6 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.1 | 0.3 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.1 | 1.7 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 1.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.1 | 0.1 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.1 | 0.5 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.0 | 0.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
| 0.0 | 0.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.0 | 0.7 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.0 | 0.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
| 0.0 | 0.5 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.0 | 1.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.0 | 0.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.0 | 0.3 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.0 | 1.0 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 1.3 | GO:0008209 | androgen metabolic process(GO:0008209) |
| 0.0 | 1.2 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 | 1.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.5 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
| 0.0 | 0.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 | 0.2 | GO:1901907 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.0 | 1.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.0 | 1.3 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.0 | 0.9 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.0 | 0.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.0 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.0 | 0.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 | 2.4 | GO:0042742 | defense response to bacterium(GO:0042742) |
| 0.0 | 0.7 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 | 3.3 | GO:0001892 | embryonic placenta development(GO:0001892) |
| 0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 0.0 | 0.5 | GO:0033189 | response to vitamin A(GO:0033189) |
| 0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 | 0.5 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.0 | 0.7 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.0 | 0.2 | GO:0039526 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.0 | 0.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
| 0.0 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 1.0 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.0 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.0 | 0.4 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.0 | 0.5 | GO:0030220 | platelet formation(GO:0030220) |
| 0.0 | 0.4 | GO:0042554 | superoxide anion generation(GO:0042554) |
| 0.0 | 0.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.0 | 0.8 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
| 0.0 | 1.8 | GO:0070671 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
| 0.0 | 0.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 | 0.1 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.0 | 0.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.0 | 0.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.0 | 1.8 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 | 0.6 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
| 0.0 | 0.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.0 | 1.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 0.3 | GO:0060039 | pericardium development(GO:0060039) |
| 0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 | 0.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 | 0.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.0 | 1.6 | GO:0031214 | biomineral tissue development(GO:0031214) |
| 0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.0 | 0.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.0 | 1.1 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
| 0.0 | 1.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 1.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 | 1.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 3.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.4 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.0 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 | 0.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 | 1.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 | 0.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.0 | 0.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
| 0.0 | 0.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 0.5 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 | 0.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.0 | 0.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 0.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 | 0.4 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 12.0 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 1.7 | 86.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 1.4 | 8.2 | GO:0032437 | cuticular plate(GO:0032437) |
| 1.2 | 23.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 1.2 | 4.7 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 1.1 | 5.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 1.1 | 3.3 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 1.0 | 8.8 | GO:0070652 | HAUS complex(GO:0070652) |
| 1.0 | 2.9 | GO:0033011 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
| 0.9 | 6.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.9 | 10.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.7 | 9.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.6 | 4.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.6 | 101.9 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.5 | 2.1 | GO:0044307 | dendritic branch(GO:0044307) |
| 0.5 | 3.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.5 | 2.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.5 | 3.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.5 | 1.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.4 | 2.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.4 | 2.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.3 | 1.7 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.3 | 11.3 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.3 | 1.0 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.3 | 1.0 | GO:0005592 | collagen type XI trimer(GO:0005592) |
| 0.3 | 10.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.3 | 1.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.3 | 0.9 | GO:0000805 | X chromosome(GO:0000805) |
| 0.3 | 7.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.3 | 0.9 | GO:0097679 | other organism cytoplasm(GO:0097679) |
| 0.3 | 0.9 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.3 | 4.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.3 | 2.6 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.3 | 1.9 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.3 | 1.9 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 5.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 2.6 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.2 | 1.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.2 | 1.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.2 | 0.8 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.2 | 2.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.2 | 0.6 | GO:0043293 | apoptosome(GO:0043293) |
| 0.2 | 11.7 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.2 | 4.9 | GO:0032982 | myosin filament(GO:0032982) |
| 0.2 | 1.8 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.2 | 0.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.2 | 1.8 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.2 | 4.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.2 | 2.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.2 | 2.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.2 | 1.0 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.2 | 1.0 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.2 | 2.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.2 | 1.8 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.2 | 4.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.2 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.2 | 6.2 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.2 | 1.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 1.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.1 | 29.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 3.3 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 1.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.1 | 1.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 1.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.1 | 2.4 | GO:0000786 | nucleosome(GO:0000786) |
| 0.1 | 2.0 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 0.1 | 3.3 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.1 | 1.2 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 1.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 3.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 1.1 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.1 | 1.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 3.4 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.1 | 6.5 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 8.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.1 | 1.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.1 | 1.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 1.2 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 8.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 1.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 2.9 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 1.5 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 2.1 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 6.1 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 5.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.1 | 1.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.1 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 1.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
| 0.1 | 2.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 2.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.1 | 1.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.1 | 0.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 2.4 | GO:0031430 | M band(GO:0031430) |
| 0.1 | 0.7 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 0.1 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.1 | 94.8 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 3.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 1.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 2.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.1 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 0.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.1 | 0.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.1 | 0.4 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.1 | 3.5 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.0 | 0.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.0 | 1.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.0 | 0.6 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.0 | 0.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.0 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.9 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.0 | 0.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 0.9 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 0.0 | 3.0 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 2.9 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.0 | 0.2 | GO:0044754 | autolysosome(GO:0044754) |
| 0.0 | 0.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.0 | 0.2 | GO:0036038 | MKS complex(GO:0036038) |
| 0.0 | 0.9 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.4 | GO:0097546 | ciliary base(GO:0097546) |
| 0.0 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.0 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
| 0.0 | 0.4 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.0 | 2.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 0.4 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.0 | 0.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.0 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 1.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.0 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.0 | 0.1 | GO:0001741 | XY body(GO:0001741) |
| 0.0 | 0.2 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 1.0 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.4 | GO:0090544 | BAF-type complex(GO:0090544) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.1 | 12.3 | GO:0035276 | ethanol binding(GO:0035276) |
| 3.0 | 30.0 | GO:0004064 | arylesterase activity(GO:0004064) |
| 2.7 | 8.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 2.5 | 10.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 2.3 | 9.0 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 1.9 | 5.6 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 1.8 | 9.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 1.6 | 378.1 | GO:0003823 | antigen binding(GO:0003823) |
| 1.6 | 9.3 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 1.4 | 11.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 1.3 | 13.0 | GO:0005549 | odorant binding(GO:0005549) |
| 1.2 | 6.0 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 1.2 | 4.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 1.1 | 3.3 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 1.1 | 3.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 1.0 | 3.0 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 1.0 | 2.9 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.9 | 2.8 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.9 | 3.6 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.9 | 12.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.8 | 3.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.8 | 2.3 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.8 | 6.2 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.8 | 3.8 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.8 | 11.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.7 | 11.0 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.7 | 2.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.7 | 2.9 | GO:0032567 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 0.7 | 2.1 | GO:0035375 | zymogen binding(GO:0035375) |
| 0.7 | 12.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.7 | 2.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.7 | 13.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.7 | 5.3 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.6 | 3.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.6 | 1.9 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 0.6 | 3.5 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.6 | 2.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.6 | 14.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.6 | 1.7 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.6 | 1.7 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.5 | 4.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.5 | 8.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.5 | 2.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.5 | 4.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.5 | 1.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.5 | 1.4 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.4 | 2.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 0.4 | 7.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.4 | 1.3 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.4 | 1.7 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) scavenger receptor binding(GO:0005124) |
| 0.4 | 1.2 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.4 | 1.6 | GO:1904492 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
| 0.4 | 1.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.4 | 1.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.4 | 1.9 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.4 | 1.5 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.4 | 5.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.4 | 1.1 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.4 | 4.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.4 | 2.5 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
| 0.4 | 1.8 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.4 | 1.4 | GO:0035473 | lipase binding(GO:0035473) |
| 0.3 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.3 | 2.0 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.3 | 2.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.3 | 1.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.3 | 1.7 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.3 | 1.0 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 0.3 | 1.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.3 | 2.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.3 | 2.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.3 | 6.5 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.3 | 1.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.3 | 1.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.3 | 1.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.3 | 4.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.3 | 2.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.3 | 3.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.3 | 0.8 | GO:0052816 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
| 0.3 | 4.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.3 | 5.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.3 | 1.1 | GO:0019862 | IgA binding(GO:0019862) |
| 0.3 | 4.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.3 | 2.5 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.2 | 0.7 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.2 | 2.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.2 | 1.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.2 | 1.4 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.2 | 2.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.2 | 1.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.2 | 7.7 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.2 | 7.2 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 4.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.2 | 0.7 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.2 | 0.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.2 | 0.7 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 0.2 | 1.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.2 | 8.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 2.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.2 | 5.8 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.2 | 1.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.2 | 1.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.2 | 2.6 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.2 | 1.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.2 | 3.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.2 | 7.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 0.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.2 | 0.6 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.2 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.2 | 0.8 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.2 | 0.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.2 | 0.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.2 | 2.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.2 | 0.7 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.2 | 0.7 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.2 | 0.6 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.2 | 1.6 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.2 | 1.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.2 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.2 | 2.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.2 | 2.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 3.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.2 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.2 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 1.9 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.2 | 6.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.2 | 1.6 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.2 | 1.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.2 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.2 | 0.9 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.2 | 0.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 1.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.2 | 0.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.2 | 2.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.2 | 1.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 6.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 4.2 | GO:0071949 | FAD binding(GO:0071949) |
| 0.1 | 1.6 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.1 | 0.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.1 | 0.4 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.1 | 1.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.1 | 1.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.1 | 0.6 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.1 | 3.7 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 0.4 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.1 | 0.4 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 0.1 | 1.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 3.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.1 | 0.8 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.1 | 0.7 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.1 | 0.4 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.1 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.1 | 0.8 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.1 | 4.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 1.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 0.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) polynucleotide phosphatase activity(GO:0098518) |
| 0.1 | 1.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.1 | 4.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 0.4 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.1 | 1.6 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.1 | 0.7 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 0.1 | 1.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.1 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 0.6 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.1 | 0.5 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.1 | 2.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.1 | 1.4 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 0.1 | 0.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.1 | 1.0 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 1.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 0.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.1 | 1.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 0.7 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.1 | 1.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 1.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.1 | 0.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
| 0.1 | 1.1 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 1.9 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.1 | 0.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 2.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.1 | 2.5 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 0.1 | 0.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.1 | 1.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 0.3 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.1 | 0.3 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.1 | 0.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 1.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 1.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 0.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.1 | 0.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
| 0.1 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.1 | 2.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 0.3 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.1 | 0.7 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 1.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 0.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 1.0 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 2.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 1.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.1 | 15.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 0.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.1 | 0.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 0.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.1 | 1.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 1.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 2.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 0.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.1 | 1.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 0.5 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 0.3 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.1 | 1.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.1 | 0.2 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.1 | 0.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.1 | 1.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 0.2 | GO:0015403 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
| 0.1 | 0.9 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.9 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
| 0.1 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.0 | 0.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.0 | 0.9 | GO:0070513 | death domain binding(GO:0070513) |
| 0.0 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
| 0.0 | 0.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.0 | 0.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 0.1 | GO:0017153 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.0 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.0 | 0.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.0 | 1.1 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
| 0.0 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.0 | 0.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.0 | 0.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.0 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 2.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 1.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.0 | 1.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.0 | 0.2 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.0 | 2.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 0.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
| 0.0 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 1.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 6.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.0 | 5.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 1.0 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 0.0 | 0.5 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.0 | 1.7 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.0 | 0.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 2.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.0 | 0.1 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.0 | 0.3 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
| 0.0 | 2.7 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.0 | 2.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.0 | 0.6 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 1.3 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 0.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 1.1 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.0 | 2.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 29.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 2.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.0 | 0.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.0 | 0.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.0 | 0.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.0 | 1.6 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.0 | 1.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 1.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.0 | 0.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.0 | 0.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 0.6 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
| 0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.0 | 0.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.0 | 0.6 | GO:0020037 | heme binding(GO:0020037) |
| 0.0 | 0.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 6.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.3 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.3 | 42.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.2 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.2 | 22.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.2 | 3.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.2 | 13.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.2 | 8.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.2 | 15.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.2 | 3.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 4.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 1.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.2 | 4.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.2 | 6.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.2 | 5.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 1.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 0.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.1 | 2.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 3.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 1.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 2.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 1.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 14.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 5.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 2.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 3.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 4.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 2.4 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.1 | 1.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 2.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 1.3 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 1.8 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 0.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 2.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 1.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 1.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 1.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 3.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 1.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 1.5 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.0 | 1.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 6.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 1.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 1.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.0 | 0.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 30.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 1.7 | 10.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 1.2 | 12.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.5 | 33.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.5 | 6.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.5 | 11.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.5 | 11.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.4 | 3.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.4 | 9.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.4 | 15.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.3 | 8.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.3 | 3.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.2 | 2.4 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.2 | 8.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 4.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.2 | 3.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.2 | 3.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.2 | 4.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.2 | 1.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.2 | 3.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 4.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.2 | 2.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 2.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 7.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.2 | 4.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 2.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 13.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.1 | 3.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.1 | 1.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.1 | 2.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.1 | 4.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 25.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 3.0 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.1 | 3.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.1 | 3.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.1 | 1.4 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 2.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 1.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.1 | 4.6 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.1 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 2.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.1 | 2.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 1.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.1 | 1.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.1 | 6.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.1 | 1.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 0.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 2.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 1.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.1 | 5.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.1 | 2.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.6 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.1 | 0.8 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.1 | 3.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 1.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.1 | 2.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 2.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.1 | 3.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.1 | 1.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 1.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.1 | 0.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.1 | 6.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 1.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 2.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 3.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 0.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.1 | 0.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 7.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 1.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 3.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 0.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 1.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 2.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 3.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.1 | 1.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 4.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 1.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.1 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.0 | 1.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.0 | 1.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 1.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.0 | 1.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.0 | 1.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 6.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.0 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.0 | 1.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.0 | 0.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 12.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.0 | 0.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.0 | 0.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.0 | 2.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.0 | 0.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.0 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 1.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |